Top compounds associated with response to LLPH


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC 0.2 0.0003
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Doxorubicin gCSI pan-cancer AAC 0.14 0.004
mRNA WP1130 CTRPv2 pan-cancer AAC -0.096 0.005
mRNA paclitaxel gCSI pan-cancer AAC 0.14 0.005
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.006
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.2 0.006
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.007
mRNA Irinotecan CCLE pan-cancer AAC 0.14 0.008
mRNA fingolimod CTRPv2 pan-cancer AAC -0.091 0.009
Download CSV